Firehorse Health is a 6–12 month behavioral science-driven program that extends the durability of psychedelic medicine — pairing licensed clinicians with an AI-adaptive digital platform that personalizes support between sessions. The two operate as one continuous system, designed to turn breakthrough experiences into lasting behavioral change.
Psychedelic medicine is opening a transformational chapter in mental health. Patients describe profound shifts after a single experience — relief from depression, anxiety, addiction, and existential distress that years of conventional treatment never delivered.
And yet, within months, most return to where they started. The window of openness closes. The insights fade. The patterns return. The science of how to make these experiences last has not yet been built into the system of care.
Firehorse Health is built to fill that gap.
Existing integration options are fragmented, limited in scope and duration, and not designed for scale. The comprehensive behavioral infrastructure that made GLP-1s, mental health treatment, and chronic disease management durable hasn't been built for psychedelics yet.
Across major depression, anxiety, and substance use disorders, roughly half of patients return to baseline within months of psychedelic intervention. The medicine creates a window. Without sustained behavioral support, it closes.
Spravato alone runs $30K per patient per year — with 2–3 re-inductions after relapse. A $3–6K integration layer can extend response durability 3× and save payors $10–15K per patient annually.
What's missing isn't just digital tools or just more clinicians — it's a system that combines both in a single program. Nothing has been built that integrates human-led care with AI-adaptive support to produce outcomes payors and employers would recognize at scale.
Psychedelics produce a brief, biologically distinct window — typically 2–8 weeks, depending on the compound — during which the brain is uniquely receptive to new patterns of thought, emotion, and behavior. Firehorse is built around this window, with licensed clinicians and an AI-adaptive digital program operating in tandem across a 6–12-month arc. Human-led care. Between-session digital support. Both adapting together.
Therapy: ACT-based processing, pattern work, preparation and integration. Coaching: lifestyle medicine, habit formation, behavioral activation. Group: peer cohort integration across the 6–12-month arc.
The digital platform reads real-time signals from each participant and personalizes support between clinical sessions — surfacing insights, personalizing content, providing in-the-moment behavioral reinforcement, and feeding data back to the care team.
Continuous measurement visualized for the participant as progress — and aggregated as peer-reviewed evidence and payor-grade data.
A glimpse into how the combined clinical program works in practice. Meet Marie — 48, Marketing Director in Chicago, navigating depression and anxiety, perimenopause, and an empty nest. Here's how Firehorse meets her in the window: what the AI surfaces, how her clinician translates that into goals, and how the program walks with her through twelve months of measurable change.
Sarah brings a rare combination of clinical depth, scientific rigor, and operational experience building digital health programs at scale. Most recently at Omada Health, she led the behavioral science and clinical outcomes strategy that shaped the go-to-market for the company's market-leading GLP-1 companion program — building the payor-relevant evidence base that helped establish Omada as the category standard and contributed to its 2025 IPO.
Her career spans academic medicine at UC San Diego and the VA healthcare system, behavioral science research with 100+ publications, and the operational work of translating evidence into programs that produce real, measurable change. The through-line: turning behavioral science into systems that scale.
Firehorse is the most important application of that work yet.
Amel Hammad · Financial & Organizational Strategy · ex-CFO, Valera Health
Kelsey Mellard · Growth & Marketing · Chief Customer Officer, Midstream Health · ex-CGO, Brightline
Lynn Marie Morski, MD, JD · Field Leadership & Category Strategy · Founder, Psychedelic Medicine Association · Host, Psychedelic Medicine Podcast
Mike Cooper, MD · Virtual Psychedelic Medicine Medical & Clinical Strategy · Former Medical Director, Innerwell
Patrick Whitaker · Psychedelic Medicine GTM, Healthcare Enterprise Strategy & VBC · Delphi
Rob Spalding · B2B2C Marketing & GTM Strategy · SVP Marketing, Carrot Fertility · ex-Omada Health · ex-Eli Lilly
Sarah Adler, PhD · Digital Mental Health, AI & Clinical Platform Building · Founder & CEO, Wave
To turn breakthrough psychedelic experiences into lasting, measurable transformation — pairing the medicine with the behavioral science that makes change hold.
A future where psychedelic medicine is more than a breakthrough — a durable foundation for healing, growth, and the reclamation of authentic life, made accessible at scale.
The Fire Horse appears once every sixty years in the Chinese zodiac — associated with intensity, courage, and self-determination.
For us, it represents reclamation: returning to yourself, making transformative decisions, and taking ownership of your life — without numbing, without outsourcing agency, and without abandoning who you are.
Firehorse Health is built for people ready for that work. Some arrive seeking recovery from burnout or psychological struggle. Others come from positions of leadership, responsibility, or outward success — sensing there is more depth, alignment, and truth available to them.
The work centers psychedelic experiences as a catalyst for insight and openness, intentionally paired with evidence-based behavioral health principles, behavior change science, and mind–body approaches to support real integration into life.
Firehorse Health isn't about becoming someone else. It's about reclaiming yourself — making clear-eyed choices, and living with the responsibility and freedom that follows.
If you're a clinician, investor, partner, or someone with lived experience in this space — we'd love to be in touch as we build.